WuXi PharmaTech To Build Largest Preclinical Drug Safety Center In China
This article was originally published in The Pink Sheet Daily
Executive Summary
U.S.-listed company’s new GLP center will focus on “highly value-added toxicology services,” VP tells PharmAsia News.